Demographics and clinical information of the group of individuals that presented PPR on EEG
| ID | Age (years) | Gender | Syndrome | Medication |
|---|---|---|---|---|
| PPR1 | 24 | M | JME | Lamotrigine |
| PPR2 | 16 | M | GTCSO | None |
| PPR3 | 15 | M | GTSO | Valproate |
| PPR4 | 13 | F | JAE | None |
| PPR5 | 15 | F | JAE | Levetiracetam, lamotrigine |
| PPR6 | 13 | F | JME | None |
| PPR7 | 16 | F | JME | Lamotrigine |
| PPR8 | 17 | F | JME | Lamotrigine |
| PPR9 | 19 | F | JAE | Clobazam |
| PPR10 | 18 | M | GTCSO | None |
| PPR11 | 16 | F | GTCSO | Levetiracetam |
| PPR12 | 17 | F | JME | Levetiracetam |
| PPR13 | 13 | F | JME | None |
| PPR14 | 24 | F | JME | Valproate |
| PPR15 | 19 | F | GTCSO | None |
| PPR16 | 22 | F | GTCSO | None |
| PPR17 | 14 | F | JME | None |
| PPR18 | 31 | F | JME | None |
| PPR19 | 18 | M | JME | None |
| PPR20 | 23 | F | GTCSO | Levetiracetam |
| PPR21 | 19 | M | GTCSO | Valproate |
| PPR22 | 23 | F | GTCSO | Sertraline |
| PPR23 | 26 | M | JME | Valproate, zonisamide |
| PPR24 | 13 | F | JME | None |
| PPR25 | 14 | F | GTCSO | None |
| PPR26 | 13 | F | JAE | None |
M, Male; F, female; GTCSO, generalized tonic-clonic seizures only.